Paper50294
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
Herberman RB and 2 others. Int J Cancer, 1975. Cited by 1,354 papers, by iCite.
Cite this record
ConductScience Library. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Papers, record 50294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/50294
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Lymphocytes | Major topic |
| Lymphoid Tissue | Major topic |
| Neoplasms, Experimental | Major topic |
| Age Factors | |
| Animals | |
| Ascitic Fluid | |
| Cell Line | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Female | |
| Lymph Nodes | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Mice, Inbred CBA | |
| Mice, Inbred NZB | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Retroviridae | |
| Sarcoma Viruses, Murine | |
| Spleen | |
| Transplantation, Homologous | |
| Transplantation, Isogeneic |
Source PubMed
Cited by404
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,354 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926223 | CAR-NK cell immunotherapy: a comprehensive review of engineering platforms, clinical applications in hematological and solid tumors. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42926223 | PubMed |
| 42904056 | Cytomics-driven insights for investigating host-pathogen interactions. | Hlife | 2026 | https://conductscience.org/library/papers/42904056 | PubMed |
| 42881185 | Next-generation natural killer cell therapy: bench to bedside and beyond. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42881185 | PubMed |
| 42769371 | Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42769371 | PubMed |
| 42046345 | Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities. | Cancer Biol Med | 2026 | https://conductscience.org/library/papers/42046345 | PubMed |
| 41986797 | PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses. | EMBO Rep | 2026 | https://conductscience.org/library/papers/41986797 | PubMed |
| 41512874 | Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy. | Cell Stem Cell | 2026 | https://conductscience.org/library/papers/41512874 | PubMed |
| 41331607 | MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41331607 | PubMed |
| 41280924 | Precision medicine with car cells in acute myeloid leukemia: where are we? | Front Immunol | 2025 | https://conductscience.org/library/papers/41280924 | PubMed |
| 41188903 | Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia. | J Transl Med | 2025 | https://conductscience.org/library/papers/41188903 | PubMed |
| 41107895 | The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41107895 | PubMed |
| 40728766 | Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses. | J Clin Immunol | 2025 | https://conductscience.org/library/papers/40728766 | PubMed |
| 40246292 | Natural killer cell-based immunotherapy for cancer. | J Immunol | 2025 | https://conductscience.org/library/papers/40246292 | PubMed |
| 40211394 | Natural killer cells: the immune frontline against circulating tumor cells. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40211394 | PubMed |
| 40149002 | The clinical landscape of CAR NK cells. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40149002 | PubMed |
| 39906666 | MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells. | Front Oncol | 2024 | https://conductscience.org/library/papers/39906666 | PubMed |
| 39754720 | Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells. | Cell Rep | 2025 | https://conductscience.org/library/papers/39754720 | PubMed |
| 39511139 | Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39511139 | PubMed |
| 39395921 | Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/39395921 | PubMed |
| 39362494 | N-803, an IL-15 Superagonist Complex as Maintenance Therapy After Allogeneic Donor Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndrome; A Phase 2 Trial. | Transplant Cell Ther | 2024 | https://conductscience.org/library/papers/39362494 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/50294
GET https://conductscience.org/api/papers/v1/50294/cited_by?page=2